BioCentury
ARTICLE | Company News

Management tracks: Grail, EUSA

December 11, 2018 12:39 AM UTC

Cancer detection company Grail Inc. (Menlo Park, Calif.) appointed Catherine Friedman chairman. She succeeds Bill Rastetter, who will continue as a director. Friedman joined Grail's board last year and also serves on the board of Radius Health Inc. (NASDAQ:RDUS). Grail also promoted co-founder Alex Aravanis to CSO and head of R&D from VP of R&D.

Cancer and rare disease company EUSA Pharma Ltd. (Hemel Hempstead, U.K.) hired Jeffrey Hackman as president of its U.S. operations. Hackman was acting CEO of Novelion Therapeutics Inc. (NASDAQ:NVLN)...